Drug Trial Radar · NCT06360796
Study of Pharmacokinetics and Metabolism on [(14)C]ADC189
Last checked: Nov 19, 2026Latest source record: Jan 20, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
6
Actual
Start
Nov 24, 2023
Primary completion
Feb 20, 2024
Study completion Feb 20, 2024
Sponsor
- Lead sponsor
- Jiaxing AnDiCon Biotech Co.,LtdIndustry
- Sponsor type
- Industry
- First posted
- Apr 11, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated drug
- No
- Who can join
- Male only, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is designed to determined the metabolism, excretion, and substance balance of almonertinib of ADC189. The pharmacokinetic characteristics and safety profile of ADC189 was investigated following a single oral dose (45 mg/100 µCi) in healthy Chinese male participants.
Conditions
- Pharmacokinetics
- Metabolism
Interventions
[(14)C]ADC189Drug
Each subject take a single oral dose of about 45 mg (about 100 μCi) \[(14)C\]ADC189 on Day 1 of the study, and be observed by 504 hours.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Area Under the Curve (AUC) of [(14)C]ADC189 and its metabolitesTime frame: 504 hours
- The Maximum Plasma Concentration [Cmax] of [(14)C]ADC189 and its metabolitesTime frame: 504 hours
- The whole blood and serum concentrations of total radioactivity of [(14)C]ADC189 (about 100 μCi)Time frame: 504 hours
- The urinary and fecal recovery of total radioactivity of [(14)C]ADC189 (about 100 μCi)Time frame: 504 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The First Affilicated Hospital of Bengbu Medical University
Bengbu, Anhui, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.